Cytocare Inc.: The Irvine-based company, which lost...

Cytocare Inc.: The Irvine-based company, which lost more than $7 million the past two years, announced Tuesday that it expects to report a small profit of an undetermined amount for the quarter ended March 31. The company, formerly called Medstone International, lost $5.1 million last year and $2.1 million in 1989, primarily due to its failure to obtain federal approval to market lithotripters--machines that crumble gallstones with shock waves. It last reported a profit in the first quarter of 1989. The reorganized company, of which Medstone is now a subsidiary, is trying to develop and acquire new health care projects so it is not dependent on lithotripters, which are still used to treat kidney stones. Cytocare’s first-quarter earnings are because of interest on investments, receipt of tax rebates and break-even performance on lithotripsy operations, the company reported.